SLC2A3 and attention deficit-hyperactivity disorder: Consistent with our findings, it has been suggested that alterations in SLC2A3 gene dosage interfere with neurodevelopment of individuals later diagnosed with a neuropsychiatric disorders, such as ADHD [87], SZ [52] and BD [53].